Real-life gait assessment in degenerative cerebellar ataxia: Towards ecologically valid biomarkers

Real-life gait assessment in degenerative cerebellar ataxia: Towards ecologically valid biomarkers

Research Area:

Clinical Movement Control and real-life Behavior Analysis for Assistive Systems

Researchers:

Winfried Ilg; Jens Seemann; Annika Thierfelder;

Collaborators:

Nathalie John; Matthis Synofzik (HIH Department of Neurodegeneration); Ludger Schoels (HIH Department of Neurodegeneration)
  

Description:

In order to establish ecologically valid biomarkers evaluating treatment-responses really in the patients’ everyday life,  we develop multi-variate measures of ataxic gait using wearable sensors, which demonstrate high sensitivity to small differences in disease severity in real-life walking. They thus represent promising candidates for motor markers for natural history and treatment trials in ecologically valid contexts (Ilg et al. 2020). Current work on the analysis of turning movements in real life walking behaviour shows that even pre-clinical mutations-carriers (yet without clinical symptoms of a manifested ataxia) reveals subtle but specific changes in the dynamic balance control during turning. Our real-life measurement protocols are now used in multi-centre studies across Europe. 

Future work will extend the analysis of real life gait behaviour to ecologically valid biomarkers (cerebellar ataxia cooperation M. Synofzik, hereditary spastic paraplegia cooperation L. Schöls ) as well as to  treatment approaches via bio-feedback (e.g. acoustic  or vibro-tactile signals). 

Moreover, we currently extend our analysis to the Online identification and quantification of ataxic-related disturbances in upperlimb everyday tasks (e.g. drinking and eating scenarios).

 

       

 

 

   

Publications

Seemann, J., Traschütz, A., Ilg, W. & Ilg, W. (2023). 4‐Aminopyridine improves real‐life gait performance in SCA27B on a single‐subject level: a prospective n‐of‐1 treatment experience. Journal of Neurology (published online 13 July 2023). [More] 
Seemann, J., Loris, T., Weber, L., Synofzik, M., Giese, M. A. & Ilg, W. (2023). One Hip Wonder: 1D-CNNs Reduce Sensor Requirements for Everyday Gait Analysis. ICANN 2023. [More] 
Ilg, W., Müller, B., Faber, J., van Gaalen, J., Hengel, H., Vogt, I. R. et al. (2022). Digital gait biomarkers, but not clinical ataxia scores, allow to capture 1-year longitudinal change in Spinocerebellar ataxia type 3 (SCA3). Movement Disorders 2022. [More] 
Thierfelder, A., Seemann, J., John, N., Harmuth, F., Giese, M. A., Schüle, R. et al. (2022). Real-Life Turning Movements Capture Subtle Longitudinal and Preataxic Changes in Cerebellar Ataxia. Movement Disorders. [More] 
Ilg, W., Seemann, J., Giese, M. A., Traschütz, A., Schöls, L., Timmann, D. et al. (2020). Real-life gait assessment in degenerative cerebellar ataxia: Towards ecologically valid biomarkers. Neurology, 95(9):e119-e210. [More]